AFP - Designers of anti-obesity drugs have suffered three major setbacks, but the potential reward from treating the world's fat epidemic is so great that their quest is unlikely to be deterred.
Read more...
Saturday, November 15, 2008
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment